https://www.dtnext.in/news/tamilnadu/regenix-puts-tn-on-indias-biosimilar-map-with-sustaglar-insulin-facility-845899
Tamil Nadu gets its first biosimilar unit; company eyes 10% share of domestic Rs 2,000-cr basal insulin market
putstnbiosimilarmapinsulin
https://www.hpnonline.com/regulatory/news/55327033/fda-announces-faster-approval-pathway-for-biosimilar-medicines
Biosimilar medicines are lower-cast generic alternatives to biologic drugs, and 76 have been approved since a pathway was set up in 2010.
fdaannouncesfasterapprovalpathway
https://www.rediff.com/business/report/usfdas-new-draft-biosimilar-rules-to-benefit-indian-biotech-cos/20251109.htm
Nov 9, 2025 - The US Food and Drug Administration's (USFDA)'s new draft guidelines aimed at speeding up and reducing the cost of developing biosimilars - lower-priced,...
newdraftbiosimilarrulesbenefit
https://www.expresspharma.in/a-biosimilar-boost-amid-trade-barriers/
Nov 12, 2025 - Even as India’s biggest pharma companies pursue biosimilars, product recalls related to manufacturing defects threaten to queer the pitch
biosimilarboostamidtradebarriers
https://www.diariomedico.com/medicina/afqlirr-primer-biosimilar-aflibercept-comercializado-espana-sandoz-oportunidad-pacientes-enfermedades-retinianas.html
Sandoz amplía su presencia en nuevas áreas terapéuticas con el lanzamiento europeo del biosimilar Afqlir® (aflibercept), una jeringa precargada de 2 mg...
primerbiosimilardeenpor
https://www.ppd.com/therapeutic-expertise/biosimilar-development/
Jun 13, 2025 - We have the proven expertise to help you execute a successful biosimilar program. Learn more about our biosimilar development services.
biosimilardevelopmentppd
https://www.sandoz.com/
Sandoz is the global leader in generic and biosimilar medicines. Our Purpose is to pioneer access to medicines for patients globally.
sandozleadingnamegenericbiosimilar